The pharmacist’s perspective to advance person- and people-centered care

Article Sidebar

Published: Mar 31, 2012
DOI: https://doi.org/10.5750/ijpcm.v2i1.94
Keywords:
Collaborative pharmacy practice drug effectiveness drug efficacy drug efficiency good pharmacy practice health policy health strategy healthcare systems evolution multidisciplinary clinical team person-centered care people-centered care pharmac

Main Article Content

Olivier Bugnon
School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Switzerland.
Saviana Di Giovanni
University of Lausanne, Switzerland.
Michel Buchmann
International Pharmaceutical Federation (FIP), Community Pharmacy Tête Noire, Romont, Switzerland.

Abstract

The International Pharmaceutical Federation (FIP) represents over 2 million pharmacists and pharmaceutical scientists and has a motto to « Advance Pharmacy Worldwide ». Over the past four decades there has been a trend for pharmacy practice to move away from its original focus on medicinal product supply towards a more inclusive focus on Person care. FIP assumes that pharmacists, in collaboration with other health care providers, can contribute to bridge the gap between the 3 E’s – efficacy, effectiveness and efficiency of medicines, which demands an urgent and fundamental evolution of health care systems.The ethical and methodological principles of Person- and People-centered care are completely integrated within the FIP 20 20 Vision, Mission and Strategic Plan (20 20 Vision means perfect vision- FIP did not set to achieve the Vision mission etc by 2020). The approach for implementing the needed change of practice is through the combination of three development axes: firstly, a research and development axis, secondly, built upon on the first, an education and coaching dimension; and thirdly, regulations for supporting practice based on quality care standards and appropriate financial incentives.

Article Details

Issue
Vol. 2 No. 1 (2012)
Section
Stakeholders’ roles and contributions beyond annual meetings: next steps to advance person- and people-centered care
Author Biographies

Olivier Bugnon, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Switzerland.

Associate Professor of Community Pharmacy Practice; Head of the Community Pharmacy, Department of Ambulatory Care & Community Medicine.

Saviana Di Giovanni, University of Lausanne, Switzerland.

Researcher in Community Pharmacy Practice, Department of Ambulatory Care & Community Medicine.

Michel Buchmann, International Pharmaceutical Federation (FIP), Community Pharmacy Tête Noire, Romont, Switzerland.

President of the International Pharmaceutical Federation (FIP); Head of the Community Pharmacy Tête Noire, Romont, Switzerland.

References

International Pharmaceutical Federation web site: http://www.fip.org/

WHO policy perspectives on medicines. Globalization, TRIPS and access to pharmaceuticals. Geneva: World Health Organization; 2001. Available at: http://www.who.int/medicines/

2020 Vision, FIP's Vision, Mission and Strategic Plan. The Hague, The Netherlands: International Pharmaceutical Federation. Available at: http://www.fip.org/www/index.php?page=menu_about

Hepler, C.D. & Strand, L.M. (1990). Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy 47, 533–543.

Developing pharmacy practice. A focus on patient care.Handbook–2006 Edition. Available at: http://www.fip.org/good_pharmacy_practice

Good Pharmacy Practice. Joint FIP/WHO Guidelines on GPP: Standards for quality of pharmacy service. The Hague, The Netherlands: International Pharmaceutical Federation; 2011. Available at: http://www.fip.org/good_pharmacy_practice

FIP Statement of Policy. Collaborative pharmacy practice. The Hague, The Netherlands: International Pharmaceutical Federation; 2010. Available at: http://www.fip.org

NHS Confederation. The new community pharmacy contract. London: Department of Health. Available at: http://www.nhsconfed.org/pharmacy

FIP and Patient Safety – Glossary of Terms. International Pharmaceutical Federation (FIP), The Hague, The Netherlands. Available at: http://fip.org/patient_safety

Advit, S. Pharmacy Intervention in the Medication-use Process – the Role of Pharmacists in Improving Patient Safety. The Hague, The Netherlands. Available at: http://fip.org/patient_safety

FIP Statement of Policy on Counterfeit Medicines. The Hague, The Netherlands. Available at: http://fip.org/counterfeit_medicines

International Medical Products Anti-Counterfeiting Taskforce – Impact. WHO. Available at: http://www.who.int/impact/en/

FIP Statement of Policy. Good pharmacy education practice. The Hague, The Netherlands: International Pharmaceutical Federation; 2000. Available at: http://www.fip.org

FIP Statements of Professional Standards. Continuing professional development. The Hague, The Netherlands: International Pharmaceutical Federation; 2002. Available at: http://www.fip.org

FIP and Pharmacy Education. The Hague, The Netherlands: International Pharmaceutical Federation; 2010. Available at: http://fip.org/?page=pharmacy_education

The FIP Academic Institutional Membership. Available at: http://aim.fip.org/

Locca, J-F., Ruggli, M., Buchmann, M., Huguenin, J.& Bugnon, O. (2009). Pharmacy World and Science 31 (2) 165-173.

Assistance pharmaceutique en EMS : le modèle fribourgeois en réseau porte ses fruits. Actualités sur le site de l’Etat de Fribourg. Available at : www.fr.ch/ww/fr/pub/functions/toutes_les_actualites.cfm?fuseaction_pre=Detail&NewsID=37563

Locca J-F., Anguish, I., Huguenin, J., Decollogny, A., Ruggli, M. & Bugnon, O. (2010). Pharmaceutical care services in Swiss nursing homes: a seven-year analysis leading to an econometric approach. Poster CPS5-P-009 presented at the 70th FIP Congress, Lisboa (Portugal).

FIP Centennial Congress- Improving health through responsible medicine use. Available at: http://fip.org/centennial/participants